M&A Deal Summary

Insulet Acquires Bigfoot Biomedical - Insulin Pump Patents

On February 13, 2023, Insulet acquired medical products company Bigfoot Biomedical - Insulin Pump Patents from Bigfoot Biomedical for 25M USD

Acquisition Highlights
  • This is Insulet’s 1st transaction in the Medical Products sector.
  • This is Insulet’s largest (disclosed) transaction.
  • This is Insulet’s 1st transaction in the United States.
  • This is Insulet’s 1st transaction in California.

M&A Deal Summary
Date 2023-02-13
Target Bigfoot Biomedical - Insulin Pump Patents
Sector Medical Products
Buyer(s) Insulet
Sellers(s) Bigfoot Biomedical
Deal Type Divestiture
Deal Value 25M USD

Target

Bigfoot Biomedical - Insulin Pump Patents

Milpitas, California, United States
Bigfoot Biomedical's Insulin Pump Patents provides automated insulin delivery (AID) technologies.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Insulet

Acton, Massachusetts, United States
Category Company
Founded 2000
Sector Medical Products
Employees3,000
Revenue 1.7B USD (2023)
DESCRIPTION

Insulet is a medical device company, which develops and manufactures insulin infusion systems for people with insulin-dependent diabetes. Insulet was founded in 2000 and is based in Acton, Massachusetts.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 2
Country (United States) 1 of 2
Year (2023) 1 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-02 Neighborhood Diabetes

Billerica, Massachusetts, United States

Neighborhood Diabetes is a distributor of diabetic testing products, insulin pumps and other medical products.

Sell $5M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-14 Automated Glucose Control

Palo Alto, California, United States

Automated Glucose Control is focused on developing and commercializing automated insulin delivery technology. Automated Glucose Control is based in Palo Alto, California.

Buy -

Seller(S) 1

SELLER

Bigfoot Biomedical

Milpitas, California, United States
Category Company
Founded 2014
Sector Medical Products
DESCRIPTION

Bigfoot Biomedical is a health solution company focused on optimizing the care of people with T1D by leveraging data, smart devices and people to deliver improved outcomes valued by patients, providers and payers. Bigfoot Biomedical was founded in 2014 and is based in Milpitas, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-08 Patients Pending

London, United Kingdom

Patients Pending Ltd. (dba Timesulin) is a manufacturer of insulin pen timer cap, and Bluetooth-enabled insulin pen dose capture technology. Timesulin was founded in 2010 and is based in London, United Kingdom.

Buy -
Mergr

Product

Company

Legal